Login to Your Account



Abbvie ups Shire offer 11 percent to $51B; higher bid to come?

By Cormac Sheridan
Staff Writer

Tuesday, July 8, 2014
DUBLIN – UK investors were unmoved Tuesday by Abbvie Inc's improved cash-and-shares indicative offer for Shire plc, which values the specialty pharma firm at £30.1 billion (US$51.3 billion), or at £51.15 per share.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription